prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 866
2021
-
FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia: Novel Therapeutic Target.
Year: 2021, type: Conference abstract
-
Functional analysis of germlineETV6 W380Rmutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia
Platelets, year: 2021, volume: 32, edition: 6, DOI
-
Functional analysis of new variant GP1BA gene in inherited macrotrombocytopenia.
Year: 2021, type: Conference abstract
-
GAB1 – novel regulator of migration capacity and tonic AKT activity in CLL: Implications for combinatorial therapy with BCR inhibitors.
Year: 2021, type: Conference abstract
-
GAB1 Regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia: novel therapeutic target
Year: 2021, type: Conference abstract
-
GAB1 reguluje tonickou AKT signalizaci a migraci buněk chronické lymfatické leukémie: implikace pro kombinační léčbu s BCR inhibitory.
Year: 2021, type: Conference abstract
-
Genetická varianta genu CTC1 u idiopatické plicní fibrózy a myelodysplastického syndromu: kazuistická sdělení
Year: 2021, type:
-
Genetické aberace u dospělých pacientů s B-other akutní lymfoblastickou leukémií v České republice se zaměřením na BCR-ABL1-like akutní lymfoblastickou leukémii.
Year: 2021, type: Conference abstract
-
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype
Acta Oncologica, year: 2021, volume: 60, edition: 6, DOI
-
Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.
Year: 2021, type: Conference abstract